American Journal of Physiology-Heart and Circulatory Physiology · 1999 · 43 citations · 33 references
Life SciencesPharmacologyPhysiologyInflammationInnate ImmunityPharmacodynamicsEndothelial ActivationHemodynamicsLeukocyte AdhesionLeukocyte RecruitmentLeukocyte TraffickingPlatelet AdhesionBlood FlowEndothelial-leukocyte InteractionsIntravital MicroscopyLeukocyte AggregationLeukocyte-endothelium InteractionsP-selectin ExpressionPlatelet-leukocyte InteractionsProinflammatory Mediators
The results of several recent studies indicate that bradykinin protects tissues against the deleterious effects of ischemia-reperfusion (I/R). However, other studies indicate that bradykinin can act as a proinflammatory agent, inducing P-selectin expression, the formation of chemotactic stimuli, and endothelial barrier disruption. In the present study, we used intravital microscopic techniques to examine the dose-dependent effects of bradykinin on leukocyte-endothelial cell interactions, the formation of platelet-leukocyte aggregates, and venular hemodynamics in rat mesentery in an attempt to explain these divergent findings. Superfusion of the mesentery with low concentrations of bradykinin (</=10(-7) M) increased venular erythrocyte velocity (V(RBC)) without increasing the number of adherent leukocytes, whereas higher concentrations (>/=10(-6) M) decreased V(RBC), increased the number of platelet-leukocyte aggregates, and induced leukocyte adhesion in single postcapillary venules. The formation of platelet-leukocyte aggregates and increased leukocyte adhesion induced by high-dose bradykinin were attenuated by administration of a B(2)-receptor (HOE-140) or a platelet-activating factor (PAF, WEB-2086) antagonist. Thus these adhesive interactions induced by high-dose bradykinin appear to be mediated by a mechanism that is dependent on B(2)-receptor activation and the formation of PAF or PAF-like lipids. The effects of bradykinin on venular V(RBC) and blood flow were also concentration dependent, with low doses producing nitric oxide-mediated vasodilation, whereas high doses decreased V(RBC) by a mechanism that is PAF independent.
33
Paul J. Simpson, Robert F. Todd, Joseph C. Fantone et al. · Journal of Clinical Investigation · 1988 · 641 citations · Full text
Medicine, Cardiology, Immunology +17
Asymptomatic Cardiac Ischemia Pilot (ACIP) Study
Peter H. Stone, Bernard Chaitman, Robert P. McMahon et al. · Circulation · 1996 · 606 citations
Ulrich Förstermann, Jennifer S. Pollock, Harald Schmidt et al. · Proceedings of the National Academy of Sciences · 1991 · 595 citations · Full text